Patent details

EP3390348 Title: DENDRIMER AND FORMULATIONS THEREOF

Basic Information

Publication number:
EP3390348
PCT Application Number:
AU2016051246
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168741478
PCT Publication Number:
WO2017100856
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DENDRIMER AND FORMULATIONS THEREOF
French Title of Invention:
DENDRIMÈRE ET FORMULATIONS DE CEUX-CI
German Title of Invention:
DENDRIMER UND FORMULIERUNGEN DARAUS
SPC Number:

Dates

Filing date:
16/12/2016
Grant date:
17/04/2024
EP Publication Date:
24/10/2018
PCT Publication Date:
22/06/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2024
EP B1 Publication Date:
17/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/12/2024
Expiration date:
16/12/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2024
 
 

Name:
Dendritic Nanotechnologies, Inc.
Address:
3005 Rocky Mountain Avenue, Loveland, CO 80538, United States (US)

Name:
Loveland Products, Inc.
Address:
3005 Rocky Mountain Avenue, Loveland, CO 80538, United States (US)

Inventor

1

Name:
KARELLAS, Peter
Address:
Australia (AU)

2

Name:
VARDHAN, Harsh
Address:
Australia (AU)

3

Name:
RAJESH, Sarigama
Address:
Australia (AU)

Priority

Priority Number:
2015905221
Priority Date:
16/12/2015
Priority Country:
Australia (AU)

Classification

IPC classification:
C07C 217/28; C07C 215/12; A01N 25/12;

Publication

European Patent Bulletin

Issue number:
202416
Publication date:
17/04/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages